Neoadjuvant chemotherapy enabling resection of stage IVA thymoma with myasthenia gravis and systemic lupus erythematosus: a case report - Poll - MDSpire

Neoadjuvant chemotherapy enabling resection of stage IVA thymoma with myasthenia gravis and systemic lupus erythematosus: a case report

  • By

  • Carlos A. Cedeno

  • Edgardo Santiago

  • Alex R. Cedeño

  • Jean Lafontaine

  • Maria J. Marcos

  • Omar Concepción

  • July 16, 2026

Share

Original Source(s)

Neoadjuvant chemotherapy enabling resection of stage IVA thymoma with myasthenia gravis and systemic lupus erythematosus: a case report

  • by Carlos A. Cedeno, Edgardo Santiago, Alex R. Cedeño, Jean Lafontaine, Maria J. Marcos, Omar Concepción

  • July 16, 2026

Related Content

Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia

Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities

Responsible artificial intelligence in medical imaging: a systematic review